REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 112 filers reported holding REPLIMUNE GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,579,423 | +47.4% | 267,646 | +100.0% | 0.01% | +50.0% |
| Q2 2023 | $3,107,370 | +21.7% | 133,823 | -7.4% | 0.00% | +33.3% |
| Q1 2023 | $2,552,983 | -29.4% | 144,563 | +8.7% | 0.00% | -25.0% |
| Q4 2022 | $3,616,594 | +107.3% | 132,963 | +26.6% | 0.00% | +100.0% |
| Q3 2022 | $1,745,000 | -4.9% | 105,001 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,835,000 | -8.1% | 105,001 | -10.7% | 0.00% | 0.0% |
| Q1 2022 | $1,996,000 | -42.6% | 117,523 | -8.4% | 0.00% | -33.3% |
| Q4 2021 | $3,479,000 | +0.5% | 128,361 | +9.9% | 0.00% | -25.0% |
| Q3 2021 | $3,461,000 | +1.4% | 116,775 | +12.0% | 0.00% | +33.3% |
| Q2 2021 | $3,413,000 | +52.3% | 104,275 | +42.0% | 0.00% | 0.0% |
| Q1 2021 | $2,241,000 | -10.7% | 73,437 | +11.6% | 0.00% | 0.0% |
| Q4 2020 | $2,510,000 | +426.2% | 65,801 | +217.9% | 0.00% | +200.0% |
| Q3 2020 | $477,000 | -7.2% | 20,700 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $514,000 | – | 20,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |